Submit Deal

Elliott Fosseprez

Principal Associate at Freshfields Bruckhaus Deringer

Lawyer

Brussels

Deal Bio

Total Deals13

Valued Deals9

Total Value£3,667M

Avg. Deal Size£407M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise (13)

Key Relationships

Sort

Belgium

Pharmaceuticals

PrivateDisposalPrivate Equity

target

Inula Group

bidder

ARDIAN

value n/a

47 dealmakers

BelgiumSpain

Copper

Private EquityMajorityAcquisitionPrivate

target

Metallo Group

bidder

Aurubis

£333m

80 dealmakers

Belgium

Nondurable Household Products

AcquisitionMajorityPrivatePrivate EquityCross Border

target

Cid Lines

bidder

Ecolab

£382m

32 dealmakers

Belgium

Mobile

MajorityAcquisitionCross BorderPrivatePrivate Equity

target

VOXBONE

bidder

BANDWIDTH

£404m

39 dealmakers

Belgium

Pharmaceuticals

AcquisitionMajorityCross BorderPrivate

target

Henogen

bidder

Thermo Fisher Scientific

£644m

39 dealmakers

United Kingdom

Real Estate Holding and Development

Private EquityAcquisitionReal EstatePrivateCross BorderMajority

target

Basecamp (pbsa Assets)

bidder

Xior Student Housing

£799m

31 dealmakers

France

Biotechnology

AcquisitionPrivateMajorityCross BorderPrivate Equity

target

SYNHELIX

bidder

UNIVERCELLS

value n/a

12 dealmakers

Germany

Glass

Cross BorderPrivateAcquisitionMajority

target

INTERPANE

bidder

Agc Glass Europe

value n/a

9 dealmakers

Belgium

Biotechnology

Cross BorderPrivate EquityMinorityAcquisitionVenture CapitalPrivate

target

UNIVERCELLS

bidder

SFPI-FPIM

£38m

14 dealmakers

Belgium

Information / Data Services

PrivateAcquisitionCross BorderMajority

target

Bisc Global

bidder

EXCELRA

value n/a

21 dealmakers

Belgium

Biotechnology

AcquisitionCross BorderMajorityPrivate

target

Univercells Technologies

bidder

Donaldson Company

£116m

13 dealmakers

Spain

Medical Services

MajorityPrivatePrivate EquityAcquisitionCross Border

target

Eugin Group

bidder

Kkr & Co

£434m

45 dealmakers

China

Pharmaceuticals

Private EquityDisposalCross BorderPrivateAcquisitionMajority

target

Ucb Pharma (chinese Neurology And Allergy Business)

bidder

Mubadala Investment Company

£514m

46 dealmakers